Oracle partners AstraZeneca for AI-enabled healthcare innovation

Eli Lilly and Company reports positive one-year results for Omvoh in paediatric ulcerative colitis

AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial

Takeda trial shows ENTYVIO reduces ulcerative colitis complication risk by nearly 70%

GSK reports 61% response rate for investigational lung cancer drug

UEG introduces new Patient Representatives Advisory Board

Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia

FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer

Edesa Biotech receives FDA clearance to expand EB06 vitiligo study into the US

LTR Pharma launches Roxus nasal spray for ED in the US

Galderma reports sustained symptom improvements with nemolizumab in children with atopic dermatitis

KDventures portfolio company Modus Therapeutics pauses Phase 2a trial enrolment, delays expected readout

Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe